{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T20:34:38Z","timestamp":1769978078656,"version":"3.49.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,8,24]],"date-time":"2019-08-24T00:00:00Z","timestamp":1566604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,8,24]],"date-time":"2019-08-24T00:00:00Z","timestamp":1566604800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005788","name":"Medical University of Vienna","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005788","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[2020,8]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Tumor dissemination and recurrence is attributed to highly resistant cancer stem cells (CSCs) which may constitute a fraction of circulating tumor cells (CTCs). Small cell lung cancer (SCLC) constitutes a suitable model to investigate the relation of CTCs and CSCs due to rapid tumor spread and a high number of CTCs. Expansion of five SCLC CTC lines (BHGc7, 10, 16, 26 and UHGc5) in vitro at our institution allowed for the analysis of CSC markers and cytotoxicity of the CSC-selective drugs salinomycin and niclosamide against CTC single cell suspensions or CTC spheroids\/ tumorospheres (TOS). Salinomycin exerted dose-dependent cytotoxicity against the SCLC lines but, with exception of BHGc7 TOS, there was no markedly enhanced activity against TOS. Similarly, niclosamide exhibits high activity against BHGc7 TOS and UHGc5 TOS but not against the other CTC spheroids. High expression of the CSC marker CD133 was restricted to three SCLC tumor lines and the BHGc10 CTC line. All SCLC CTCs are CD24-positive but lack expression of CD44 and ABCG2 in contrast to the SCLC tumor lines which show a phenotype more similar to that of CSCs. The stem cell marker SOX2 was found in all CTC lines and SCLC GLC14\/16, whereas elevated expression of Oct-3\/4 and Nanog was restricted to BHGc26 and UHGc5. In conclusion, the SCLC CTCs established from patients with relapsed disease lack a typical CSC phenotype in respect to chemosensitivity to CSC-selective drugs, surface markers, expression of pluripotent stem cell and transcription factors.<\/jats:p>","DOI":"10.1007\/s10637-019-00847-8","type":"journal-article","created":{"date-parts":[[2019,8,24]],"date-time":"2019-08-24T12:02:31Z","timestamp":1566648151000},"page":"946-955","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Effects of salinomycin and niclosamide on small cell lung cancer and small cell lung cancer circulating tumor cell lines"],"prefix":"10.1007","volume":"38","author":[{"given":"Maximilian","family":"Hochmair","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Rath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lukas","family":"Klameth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernst","family":"Ulsperger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Weinlinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Fazekas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adelina","family":"Plangger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Zeillinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerhard","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,8,24]]},"reference":[{"issue":"13","key":"847_CR1","doi-asserted-by":"crossref","first-page":"10697","DOI":"10.18632\/oncotarget.4037","volume":"6","author":"A Mitra","year":"2015","unstructured":"Mitra A, Mishra L, Li S (2015) EMT, CTCs and CSCs in tumor relapse and drug-resistance. Oncotarget 6(13):10697\u201310711","journal-title":"Oncotarget"},{"issue":"1","key":"847_CR2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/cas.12817","volume":"107","author":"GJ Yoshida","year":"2016","unstructured":"Yoshida GJ, Saya H (2016) Therapeutic strategies targeting cancer stem cells. Cancer Sci 107(1):5\u201311","journal-title":"Cancer Sci"},{"issue":"6219","key":"847_CR3","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1126\/science.347.6219.226","volume":"347","author":"J Kaiser","year":"2015","unstructured":"Kaiser J (2015) The cancer stem cell gamble. Science 347(6219):226\u2013229","journal-title":"Science"},{"key":"847_CR4","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3389\/fcell.2019.00016","volume":"7","author":"A Turdo","year":"2019","unstructured":"Turdo A, Veschi V, Gaggianesi M, Chinnici A, Bianca P, Todaro M, Stassi G (2019) Meeting the challenge of targeting Cancer stem cells. Front Cell Dev Biol 7:16","journal-title":"Front Cell Dev Biol"},{"issue":"21","key":"847_CR5","doi-asserted-by":"crossref","first-page":"4779","DOI":"10.1111\/febs.13023","volume":"281","author":"S Colak","year":"2014","unstructured":"Colak S, Medema JP (2014) Cancer stem cells--important players in tumor therapy resistance. FEBS J 281(21):4779\u20134791","journal-title":"FEBS J"},{"key":"847_CR6","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ejmech.2018.12.057","volume":"164","author":"M Antoszczak","year":"2019","unstructured":"Antoszczak M (2019) A medicinal chemistry perspective on salinomycin as a potent anticancer and anti-CSCs agent. Eur J Med Chem 164:366\u2013377","journal-title":"Eur J Med Chem"},{"issue":"8","key":"847_CR7","doi-asserted-by":"publisher","first-page":"622","DOI":"10.3109\/09553002.2014.886798","volume":"90","author":"I Tinhofer","year":"2014","unstructured":"Tinhofer I, Saki M, Niehr F, Keilholz U, Budach V (2014) Cancer stem cell characteristics of circulating tumor cells. Int J Radiat Biol 90(8):622\u2013627. https:\/\/doi.org\/10.3109\/09553002.2014.886798","journal-title":"Int J Radiat Biol"},{"issue":"11","key":"847_CR8","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.trecan.2017.08.007","volume":"3","author":"EK Ramos","year":"2017","unstructured":"Ramos EK, Hoffmann AD, Gerson SL, Liu H (2017) New opportunities and challenges to defeat Cancer stem cells. Trends Cancer 3(11):780\u2013796. https:\/\/doi.org\/10.1016\/j.trecan.2017.08.007","journal-title":"Trends Cancer"},{"key":"847_CR9","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.semcancer.2017.03.003","volume":"44","author":"A Agliano","year":"2017","unstructured":"Agliano A, Calvo A, Box C (2017) The challenge of targeting cancer stem cells to halt metastasis. Semin Cancer Biol 44:25\u201342. https:\/\/doi.org\/10.1016\/j.semcancer.2017.03.003","journal-title":"Semin Cancer Biol"},{"issue":"10","key":"847_CR10","doi-asserted-by":"crossref","first-page":"13059","DOI":"10.1007\/s13277-016-5294-5","volume":"37","author":"P Ranji","year":"2016","unstructured":"Ranji P, Salmani Kesejini T, Saeedikhoo S, Alizadeh AM (2016) Targeting cancer stem cell-specific markers and\/or associated signaling pathways for overcoming cancer drug resistance. Tumour Biol 37(10):13059\u201313075","journal-title":"Tumour Biol"},{"issue":"10","key":"847_CR11","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/nrc2499","volume":"8","author":"JE Visvader","year":"2008","unstructured":"Visvader JE, Lindeman GJ (2008) Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 8(10):755\u2013768. https:\/\/doi.org\/10.1038\/nrc2499","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"847_CR12","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1002\/path.2793","volume":"223","author":"MR Alison","year":"2001","unstructured":"Alison MR, Lim SM, Nicholson LJ (2001) Cancer stem cells: problems for therapy? J Pathol 223(2):147\u2013161. https:\/\/doi.org\/10.1002\/path.2793","journal-title":"J Pathol"},{"key":"847_CR13","doi-asserted-by":"crossref","unstructured":"Thapa R, Wilson GD (2016) The importance of CD44 as a stem cell biomarker and therapeutic target in Cancer. Stem Cells Int:2087204","DOI":"10.1155\/2016\/2087204"},{"issue":"5","key":"847_CR14","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1080\/07357900801904140","volume":"26","author":"A Shervington","year":"2008","unstructured":"Shervington A, Lu C (2008) Expression of multidrug resistance genes in normal and cancer stem cells. Cancer Invest 26(5):535\u2013542","journal-title":"Cancer Invest"},{"issue":"2","key":"847_CR15","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/emmm.200900019","volume":"1","author":"A Viale","year":"2009","unstructured":"Viale A, Pelicci PG (2009) Awaking stem cells from dormancy: growing old and fighting cancer. EMBO Mol Med 1(2):88\u201391. https:\/\/doi.org\/10.1002\/emmm.200900019","journal-title":"EMBO Mol Med"},{"issue":"11","key":"847_CR16","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/onc.2016.304","volume":"36","author":"T Zhan","year":"2016","unstructured":"Zhan T, Rindtorff N, Boutros M (2016) Wnt signaling in cancer. Oncogene 36(11):1461\u20131473","journal-title":"Oncogene"},{"key":"847_CR17","doi-asserted-by":"crossref","unstructured":"de Sousa EMF, Vermeulen L (2016) Wnt signaling in cancer stem cell biology. Cancers (Basel) 8(7)","DOI":"10.3390\/cancers8070060"},{"issue":"4","key":"847_CR18","doi-asserted-by":"crossref","first-page":"4241","DOI":"10.1007\/s13277-015-4407-x","volume":"37","author":"S S\u0142awek","year":"2016","unstructured":"S\u0142awek S, Szmyt K, Fularz M, Dziudzia J, Boruczkowski M, Sikora J, Kaczmarek M (2016) Pluripotency transcription factors in lung cancer-a review. Tumour Biol 37(4):4241\u20134249","journal-title":"Tumour Biol"},{"issue":"9","key":"847_CR19","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/bjc.2011.94","volume":"104","author":"R Xiang","year":"2011","unstructured":"Xiang R, Liao D, Cheng T, Zhou H, Shi Q, Chuang TS, Markowitz D, Reisfeld RA, Luo Y (2011) Downregulation of transcription factor SOX2 in cancer stem cells suppresses growth and metastasis of lung cancer. Br J Cancer 104(9):1410\u20131417","journal-title":"Br J Cancer"},{"issue":"2","key":"847_CR20","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1515\/raon-2015-0027","volume":"50","author":"E Sodja","year":"2016","unstructured":"Sodja E, Rijavec M, Koren A, Sadikov A, Koro\u0161ec P, Cufer T (2016) The prognostic value of whole blood SOX2, NANOG and OCT4 mRNA expression in advanced small-cell lung cancer. Radiol Oncol 50(2):188\u2013196","journal-title":"Radiol Oncol"},{"issue":"9","key":"847_CR21","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1042\/BCJ20170164","volume":"475","author":"EM De Francesco","year":"2018","unstructured":"De Francesco EM, Sotgia F, Lisanti MP (2018) Cancer stem cells (CSCs): metabolic strategies for their identification and eradication. Biochem J 475(9):1611\u20131634. https:\/\/doi.org\/10.1042\/BCJ20170164","journal-title":"Biochem J"},{"issue":"7","key":"847_CR22","doi-asserted-by":"publisher","first-page":"827","DOI":"10.14670\/HH-28.827","volume":"28","author":"J Dittmer","year":"2013","unstructured":"Dittmer J, Rody A (2013) Cancer stem cells in breast cancer. Histol Histopathol 28(7):827\u2013838. https:\/\/doi.org\/10.14670\/HH-28.827","journal-title":"Histol Histopathol"},{"issue":"4","key":"847_CR23","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.cell.2009.06.034","volume":"138","author":"PB Gupta","year":"2009","unstructured":"Gupta PB, Onder TT, Jiang G, Tao K, Kuperwasser C, Weinberg RA, Lander ES (2009) Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell 138(4):645\u2013659","journal-title":"Cell"},{"issue":"2","key":"847_CR24","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.canlet.2014.12.037","volume":"358","author":"M Schenk","year":"2015","unstructured":"Schenk M, Aykut B, Teske C, Giese NA, Weitz J, Welsch T (2015) Salinomycin inhibits growth of pancreatic cancer and cancer cell migration by disruption of actin stress fiber integrity. Cancer Lett 358(2):161\u2013169","journal-title":"Cancer Lett"},{"issue":"6","key":"847_CR25","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1245\/s10434-011-1561-2","volume":"18","author":"TT Dong","year":"2011","unstructured":"Dong TT, Zhou HM, Wang LL, Feng B, Lv B, Zheng MH (2011) Salinomycin selectively targets CD133+ cell subpopulations and decreases malignant traits in colorectal cancer lines. Ann Surg Oncol 18(6):1797\u20131804","journal-title":"Ann Surg Oncol"},{"key":"847_CR26","first-page":"36","volume":"2","author":"C Naujokat","year":"2013","unstructured":"Naujokat C, Laufer S (2013) Targeting Cancer stem cells with defined compounds and drugs. J Cancer Res Updates 2:36\u201367","journal-title":"J Cancer Res Updates"},{"key":"847_CR27","doi-asserted-by":"crossref","first-page":"950658","DOI":"10.1155\/2012\/950658","volume":"2012","author":"C Naujokat","year":"2012","unstructured":"Naujokat C, Steinhart R (2012) Salinomycin as a drug for targeting human cancer stem cells. J Biomed Biotechnol 2012:950658","journal-title":"J Biomed Biotechnol"},{"key":"847_CR28","doi-asserted-by":"crossref","unstructured":"Pizon M, Schott D, Pachmann U, Pachmann K, Szalus N (2018) Salinomycin kills not only circulating epithelial tumor cells (CETCs) but also circulating cancer stem cells (cCSC) and may potentially prevent progression in patients with breast cancer. Mol Cancer Ther 17(1 Suppl) Abstract A067","DOI":"10.1158\/1535-7163.TARG-17-A067"},{"issue":"6","key":"847_CR29","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1021\/acscentsci.8b00257","volume":"4","author":"X Huang","year":"2018","unstructured":"Huang X, Borgstr\u00f6m B, Stegmayr J, Abassi Y, Kruszyk M, Leffler H, Persson L, Albinsson S, Massoumi R, Scheblykin IG, Hegardt C, Oredsson S, Strand D (2018) The molecular basis for inhibition of Stemlike Cancer cells by Salinomycin. ACS Cent Sci 4(6):760\u2013767. https:\/\/doi.org\/10.1021\/acscentsci.8b00257","journal-title":"ACS Cent Sci"},{"issue":"1","key":"847_CR30","doi-asserted-by":"publisher","first-page":"12776","DOI":"10.1038\/s41598-018-30692-3","volume":"8","author":"LH Wang","year":"2018","unstructured":"Wang LH, Xu M, Fu LQ, Chen XY, Yang F (2018) The Antihelminthic Niclosamide inhibits Cancer Stemness, extracellular matrix remodeling, and metastasis through dysregulation of the nuclear \u03b2-catenin\/c-Myc axis in OSCC. Sci Rep 8(1):12776. https:\/\/doi.org\/10.1038\/s41598-018-30692-3","journal-title":"Sci Rep"},{"issue":"11","key":"847_CR31","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/cmdc.201800100","volume":"13","author":"H Kadri","year":"2018","unstructured":"Kadri H, Lambourne OA, Mehellou Y (2018) Niclosamide, a drug with many (re)purposes. ChemMedChem 13(11):1088\u20131091","journal-title":"ChemMedChem"},{"issue":"5","key":"847_CR32","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3978\/j.issn.1000-9604.2015.04.08","volume":"27","author":"MH Yang","year":"2015","unstructured":"Yang MH, Imrali A, Heeschen C (2015) Circulating cancer stem cells: the importance to select. Chin J Cancer Res 27(5):437\u2013449. https:\/\/doi.org\/10.3978\/j.issn.1000-9604.2015.04.08","journal-title":"Chin J Cancer Res"},{"issue":"1","key":"847_CR33","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13046-018-0685-7","volume":"37","author":"YT Luo","year":"2018","unstructured":"Luo YT, Cheng J, Feng X, He SJ, Wang YW, Huang Q (2018) The viable circulating tumor cells with cancer stem cells feature, where is the way out? J Exp Clin Cancer Res 37(1):38. https:\/\/doi.org\/10.1186\/s13046-018-0685-7","journal-title":"J Exp Clin Cancer Res"},{"issue":"4","key":"847_CR34","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.trecan.2016.02.006","volume":"2","author":"G Hamilton","year":"2016","unstructured":"Hamilton G, Moser D, Hochmair M (2016) Metastasis: circulating tumor cells in small cell lung Cancer. Trends Cancer 2(4):159\u2013160. https:\/\/doi.org\/10.1016\/j.trecan.2016.02.006","journal-title":"Trends Cancer"},{"issue":"1","key":"847_CR35","doi-asserted-by":"publisher","first-page":"5337","DOI":"10.1038\/s41598-017-05562-z","volume":"7","author":"L Klameth","year":"2017","unstructured":"Klameth L, Rath B, Hochmaier M, Moser D, Redl M, Mungenast F, Gelles K, Ulsperger E, Zeillinger R, Hamilton G (2017) Small cell lung cancer: model of circulating tumor cell tumorospheres in chemoresistance. Sci Rep 7(1):5337. https:\/\/doi.org\/10.1038\/s41598-017-05562-z","journal-title":"Sci Rep"},{"issue":"14","key":"847_CR36","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1101\/gad.263145.115","volume":"29","author":"EA Semenova","year":"2015","unstructured":"Semenova EA, Nagel R, Berns A (2015) Origins, genetic landscape, and emerging therapies of small cell lung cancer. Genes Dev 29(14):1447\u20131462","journal-title":"Genes Dev"},{"issue":"10","key":"847_CR37","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1634\/theoncologist.2009-0026","volume":"14","author":"JL Hurwitz","year":"2009","unstructured":"Hurwitz JL, McCoy F, Scullin P, Fennell DA (2009) New advances in the second-line treatment of small cell lung cancer. Oncologist 14(10):986\u2013994","journal-title":"Oncologist"},{"issue":"1","key":"847_CR38","first-page":"2","volume":"5","author":"N Karachaliou","year":"2016","unstructured":"Karachaliou N, Pilotto S, Lazzari C, Bria E, de Marinis F, Rosell R (2016) Cellular and molecular biology of small cell lung cancer: an overview. Transl Lung Cancer Res 5(1):2\u201315","journal-title":"Transl Lung Cancer Res"},{"issue":"19","key":"847_CR39","doi-asserted-by":"crossref","first-page":"5615","DOI":"10.1158\/1078-0432.CCR-06-0169","volume":"12","author":"M Balic","year":"2006","unstructured":"Balic M, Lin H, Young L, Hawes D, Giuliano A, McNamara G, Datar RH, Cote RJ (2006) Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype. Clin Cancer Res 12(19):5615\u20135621","journal-title":"Clin Cancer Res"},{"issue":"1","key":"847_CR40","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.canlet.2009.06.027","volume":"288","author":"PA Theodoropoulos","year":"2010","unstructured":"Theodoropoulos PA, Polioudaki H, Agelaki S, Kallergi G, Saridaki Z, Mavroudis D, Georgoulias V (2010) Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer. Cancer Lett 288(1):99\u2013106","journal-title":"Cancer Lett"},{"issue":"23","key":"847_CR41","first-page":"6891","volume":"48","author":"H Berendsen","year":"1988","unstructured":"Berendsen H, de Leij L, de Vries EG, Mesander G, Mulder NH, de Jong B, Buys CH, Postmus PE, Poppema S, Sluiter HJ (1988) Characterization of three small cell lung cancer cell lines established from one patient during longitudinal follow-up. Cancer Res 48(23):6891\u20136899","journal-title":"Cancer Res"},{"issue":"15","key":"847_CR42","first-page":"4175","volume":"9","author":"EG de Vries","year":"1989","unstructured":"de Vries EG, Meijer C, Timmer-Bosscha H, Berendsen HH, de Leij L, Scheper RJ, Mulder NH (1989) Resistance mechanisms in three human small cell lung cancer cell lines established from one patient during clinical follow-up. Cancer Res 9(15):4175\u20134178","journal-title":"Cancer Res"},{"issue":"3","key":"847_CR43","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00408-015-9725-7","volume":"193","author":"G Hamilton","year":"2015","unstructured":"Hamilton G, Burghuber O, Zeillinger R (2015) Circulating tumor cells in small cell lung cancer: ex vivo expansion. Lung 193(3):451\u2013452","journal-title":"Lung"},{"issue":"4","key":"847_CR44","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1080\/19336918.2016.1155019","volume":"10","author":"G Hamilton","year":"2016","unstructured":"Hamilton G, Hochmair M, Rath B, Klameth L, Zeillinger R (2016) Small cell lung cancer: circulating tumor cells of extended stage patients express a mesenchymal-epithelial transition phenotype. Cell Adhes Migr 10(4):360\u2013367","journal-title":"Cell Adhes Migr"},{"issue":"3","key":"847_CR45","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.3892\/mmr.2016.5524","volume":"14","author":"W Zhao","year":"2016","unstructured":"Zhao W, Luo Y, Li B, Zhang T (2016) Tumorigenic lung tumorospheres exhibit stem-like features with significantly increased expression of CD133 and ABCG2. Mol Med Rep 14(3):2598\u20132606","journal-title":"Mol Med Rep"},{"issue":"7","key":"847_CR46","doi-asserted-by":"crossref","first-page":"629","DOI":"10.18632\/oncoscience.179","volume":"2","author":"G Hamilton","year":"2015","unstructured":"Hamilton G, Rath B, Klameth L, Hochmair M (2015) Receptor tyrosine kinase expression of circulating tumor cells in small cell lung cancer. Oncoscience 2(7):629\u2013634","journal-title":"Oncoscience"},{"issue":"3","key":"847_CR47","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1093277","volume":"5","author":"G Hamilton","year":"2015","unstructured":"Hamilton G, Rath B, Klameth L, Hochmair MJ (2015) Small cell lung cancer: recruitment of macrophages by circulating tumor cells. Oncoimmunology 5(3):e1093277","journal-title":"Oncoimmunology"},{"issue":"1","key":"847_CR48","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.canlet.2011.07.016","volume":"311","author":"QL Tang","year":"2011","unstructured":"Tang QL, Zhao ZQ, Li JC, Liang Y, Yin JQ, Zou CY, Xie XB, Zeng YX, Shen JN, Kang T, Wang J (2011) Salinomycin inhibits osteosarcoma by targeting its tumor stem cells. Cancer Lett 311(1):113\u2013121. https:\/\/doi.org\/10.1016\/j.canlet.2011.07.016","journal-title":"Cancer Lett"},{"issue":"5","key":"847_CR49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095970","volume":"9","author":"J Klose","year":"2014","unstructured":"Klose J, Stankov MV, Kleine M, Ramackers W, Panayotova-Dimitrova D, J\u00e4ger MD, Klempnauer J, Winkler M, Bektas H, Behrens GM, Vondran FW (2014) Inhibition of autophagic flux by salinomycin results in anti-cancer effect in hepatocellular carcinoma cells. PLoS One 9(5):e95970","journal-title":"PLoS One"},{"issue":"33","key":"847_CR50","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.2174\/15672050113109990199","volume":"20","author":"S Zhou","year":"2013","unstructured":"Zhou S, Wang F, Wong ET, Fonkem E, Hsieh TC, Wu JM, Wu E (2013) Salinomycin: a novel anti-cancer agent with known anti-coccidial activities. Curr Med Chem 20(33):4095\u20134101","journal-title":"Curr Med Chem"},{"key":"847_CR51","first-page":"295760","volume":"2014","author":"AR Choi","year":"2014","unstructured":"Choi AR, Kim JH, Yoon S (2014) Sensitization of cancer cells through reduction of total Akt and downregulation of salinomycin-induced pAkt, pGSk3beta, pTSC2, and p4EBP1 by cotreatment with MK- 2206. Biomed Res Int 2014:295760","journal-title":"Biomed Res Int"},{"key":"847_CR52","doi-asserted-by":"crossref","unstructured":"Ahmed K, Shaw HV, Koval A, Katanaev VL (2016) A second WNT for old drugs: drug repositioning against WNT-dependent cancers. Cancers (Basel) 8(7)","DOI":"10.3390\/cancers8070066"},{"issue":"10","key":"847_CR53","first-page":"352","volume":"7","author":"A Ragunathan","year":"2015","unstructured":"Ragunathan A, Ravi L (2015) Molecular docking analysis of anticancerous interactions of salinomycin. J Chem Pharm Res 7(10):352\u2013357","journal-title":"J Chem Pharm Res"},{"issue":"1","key":"847_CR54","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.canlet.2014.04.003","volume":"349","author":"Y Li","year":"2014","unstructured":"Li Y, Li PK, Roberts MJ, Arend RC, Samant RS, Buchsbaum DJ (2014) Multi-targeted therapy of cancer by niclosamide: a new application for an old drug. Cancer Lett 349(1):8\u201314","journal-title":"Cancer Lett"},{"key":"847_CR55","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.canlet.2018.06.034","volume":"433","author":"MM Chan","year":"2018","unstructured":"Chan MM, Chen R, Fong D (2018) Targeting cancer stem cells with dietary phytochemical - repositioned drug combinations. Cancer Lett 433:53\u201364. https:\/\/doi.org\/10.1016\/j.canlet.2018.06.034","journal-title":"Cancer Lett"},{"key":"847_CR56","first-page":"142","volume":"2","author":"G Hamilton","year":"2017","unstructured":"Hamilton G, Rath B (2017) Repurposing of Anthelminthics as anticancer drugs. Oncomedicine 2:142\u2013149","journal-title":"Oncomedicine"},{"issue":"1","key":"847_CR57","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1038\/s41467-018-05805-1","volume":"9","author":"R Kumar","year":"2018","unstructured":"Kumar R, Coronel L, Somalanka B, Raju A, Aning OA, An O, Ho YS, Chen S, Mak SY, Hor PY, Yang H, Lakshmanan M, Itoh H, Tan SY, Lim YK, Wong APC, Chew SH, Huynh TH, Goh BC, Lim CY, Tergaonkar V, Cheok CF (2018) Mitochondrial uncoupling reveals a novel therapeutic opportunity for p53-defective cancers. Nat Commun 9(1):3931","journal-title":"Nat Commun"},{"issue":"4","key":"847_CR58","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1093\/carcin\/bgw092","volume":"38","author":"A Molchadsky","year":"2017","unstructured":"Molchadsky A, Rotter V (2017) p53 and its mutants on the slippery road from stemness to carcinogenesis. Carcinogenesis. 38(4):347\u2013358. https:\/\/doi.org\/10.1093\/carcin\/bgw092","journal-title":"Carcinogenesis."},{"issue":"11","key":"847_CR59","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/j.humpath.2008.03.008","volume":"39","author":"LK Koch","year":"2008","unstructured":"Koch LK, Zhou H, Ellinger J, Biermann K, H\u00f6ller T, von R\u00fccker A, B\u00fcttner R, G\u00fctgemann I (2008) Stem cell marker expression in small cell lung carcinoma and developing lung tissue. Hum Pathol 39(11):1597\u20131605","journal-title":"Hum Pathol"},{"issue":"3","key":"847_CR60","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/3ff065bf-8100-4ddd-be5b-88f81ffcfe04","volume":"8","author":"P Wang","year":"2013","unstructured":"Wang P, Gao Q, Suo Z, Munthe E, Solberg S, Ma L, Wang M, Westerdaal NA, Kvalheim G, Gaudernack G (2013) Identification and characterization of cells with cancer stem cell properties in human primary lung cancer cell lines. PLoS One 8(3):e57020","journal-title":"PLoS One"},{"issue":"3","key":"847_CR61","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/sj.cdd.4402283","volume":"15","author":"A Eramo","year":"2008","unstructured":"Eramo A, Lotti F, Sette G, Pilozzi E, Biffoni M, Di Virgilio A, Conticello C, Ruco L, Peschle C, De Maria R (2008) Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ 15(3):504\u2013514","journal-title":"Cell Death Differ"},{"issue":"1","key":"847_CR62","first-page":"16","volume":"5","author":"J Codony-Servat","year":"2016","unstructured":"Codony-Servat J, Verlicchi A, Rosell R (2016) Cancer stem cells in small cell lung cancer. Transl Lung Cancer Res 5(1):16\u201325","journal-title":"Transl Lung Cancer Res"},{"issue":"11","key":"847_CR63","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1038\/sj.bjc.6605668","volume":"102","author":"CD Salcido","year":"2010","unstructured":"Salcido CD, Larochelle A, Taylor BJ, Dunbar CE, Varticovski L (2010) Molecular characterisation of side population cells with cancer stem cell-like characteristics in small-cell lung cancer. Br J Cancer 102(11):1636\u20131644","journal-title":"Br J Cancer"},{"key":"847_CR64","volume":"4","author":"Z Zhang","year":"2013","unstructured":"Zhang Z, Zhou Y, Qian H, Shao G, Lu X, Chen Q, Sun X, Chen D, Yin R, Zhu H, Shao Q, Xu W (2013) Stemness and inducing differentiation of small cell lung cancer NCI-H446 cells. Cell Death Dis 4:e633","journal-title":"Cell Death Dis"},{"issue":"5","key":"847_CR65","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1158\/0008-5472.CAN-13-1541","volume":"74","author":"S Sarvi","year":"2014","unstructured":"Sarvi S, Mackinnon AC, Avlonitis N, Bradley M, Rintoul RC, Rassl DM, Wang W, Forbes SJ, Gregory CD, Sethi T (2014) CD133+ cancer stem-like cells in small cell lung cancer are highly tumorigenic and chemoresistant but sensitive to a novel neuropeptide antagonist. Cancer Res 74(5):1554\u20131565","journal-title":"Cancer Res"},{"issue":"2","key":"847_CR66","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0000243","volume":"2","author":"M Gutova","year":"2007","unstructured":"Gutova M, Najbauer J, Gevorgyan A, Metz MZ, Weng Y, Shih CC, Aboody KS (2007) Identification of uPAR-positive chemoresistant cells in small cell lung cancer. PLoS One 2(2):e243","journal-title":"PLoS One"},{"issue":"1","key":"847_CR67","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/cas.12045","volume":"104","author":"T Kubo","year":"2013","unstructured":"Kubo T, Takigawa N, Osawa M, Harada D, Ninomiya T, Ochi N, Ichihara E, Yamane H, Tanimoto M, Kiura K (2013) Subpopulation of small-cell lung cancer cells expressing CD133 and CD87 show resistance to chemotherapy. Cancer Sci 104(1):78\u201384","journal-title":"Cancer Sci"},{"issue":"4","key":"847_CR68","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.ccell.2016.09.001","volume":"30","author":"G Ferone","year":"2016","unstructured":"Ferone G, Song JY, Sutherland KD, Bhaskaran R, Monkhorst K, Lambooij JP, Proost N, Gargiulo G, Berns A (2016) SOX2 is the determining oncogenic switch in promoting lung squamous cell carcinoma from different cells of origin. Cancer Cell 30(4):519\u2013532","journal-title":"Cancer Cell"},{"key":"847_CR69","doi-asserted-by":"publisher","first-page":"981261","DOI":"10.1155\/2014\/981261","volume":"2014","author":"M Li","year":"2014","unstructured":"Li M, Zhang B, Zhang Z, Liu X, Qi X, Zhao J, Jiang Y, Zhai H, Ji LD (2014) Stem cell-like circulating tumor cells indicate poor prognosis in gastric cancer. Biomed Res Int 2014:981261\u2013981267. https:\/\/doi.org\/10.1155\/2014\/981261","journal-title":"Biomed Res Int"},{"issue":"2","key":"847_CR70","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s13277-011-0303-1","volume":"33","author":"N Wang","year":"2012","unstructured":"Wang N, Shi L, Li H, Hu Y, Du W, Liu W, Zheng J, Huang S, Qu X (2012) Detection of circulating tumor cells and tumor stem cells in patients with breast cancer by using flow cytometry: a valuable tool for diagnosis and prognosis evaluation. Tumour Biol 33(2):561\u2013569","journal-title":"Tumour Biol"},{"issue":"8","key":"847_CR71","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/nm.3600","volume":"20","author":"CL Hodgkinson","year":"2014","unstructured":"Hodgkinson CL, Morrow CJ, Li Y, Metcalf RL, Rothwell DG, Trapani F, Polanski R, Burt DJ, Simpson KL, Morris K, Pepper SD, Nonaka D, Greystoke A, Kelly P, Bola B, Krebs MG, Antonello J, Ayub M, Faulkner S, Priest L, Carter L, Tate C, Miller CJ, Blackhall F, Brady G, Dive C (2014) Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer. Nat Med 20(8):897\u2013903","journal-title":"Nat Med"},{"issue":"18","key":"847_CR72","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1038\/onc.2010.35","volume":"29","author":"MQ Gao","year":"2010","unstructured":"Gao MQ, Choi YP, Kang S, Youn JH, Cho NH (2010) CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells. Oncogene 29(18):2672\u20132680","journal-title":"Oncogene"},{"issue":"4","key":"847_CR73","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/ncb2717","volume":"15","author":"JP Medema","year":"2013","unstructured":"Medema JP (2013) Cancer stem cells: the challenges ahead. Nat Cell Biol 15(4):338\u2013344","journal-title":"Nat Cell Biol"},{"key":"847_CR74","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13062-016-0135-4","volume":"11","author":"S Gkountela","year":"2016","unstructured":"Gkountela S, Aceto N (2016) Stem-like features of cancer cells on their way to metastasis. Biol Direct 11:33","journal-title":"Biol Direct"},{"issue":"1","key":"847_CR75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neo.2014.12.004","volume":"17","author":"LB Weiswald","year":"2015","unstructured":"Weiswald LB, Bellet D, Dangles-Marie V (2015) Spherical cancer models in tumor biology. Neoplasia 17(1):1\u201315","journal-title":"Neoplasia"},{"key":"847_CR76","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1101\/sqb.2008.73.024","volume":"73","author":"SI Nishikawa","year":"2008","unstructured":"Nishikawa SI, Osawa M, Yonetani S, Torikai-Nishikawa S, Freter R (2008) Niche required for inducing quiescent stem cells. Cold Spring Harb Symp Quant Biol 73:67\u201371","journal-title":"Cold Spring Harb Symp Quant Biol"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-019-00847-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10637-019-00847-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-019-00847-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T04:39:35Z","timestamp":1678509575000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10637-019-00847-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,24]]},"references-count":76,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["847"],"URL":"https:\/\/doi.org\/10.1007\/s10637-019-00847-8","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,24]]},"assertion":[{"value":"21 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"M Hochmair declares that he has no conflict of interest. B Rath declares that she has no conflict of interest. L Klameth declares that he has no conflict of interest. E Ulsperger declares that he has no conflict of interest. C Weinlinger declares that he has no conflict of interest. A Fazekas declares that he has no conflict of interest. A Plangger declares that she has no conflict of interest. R Zeillinger declares that he has no conflict of interest. G Hamilton declares that he has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This manuscript does not contain any experiments with human subjects or animals conducted by any of the contributing authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"It is a preclinical study. Therefore, formal consent is not required for this type of study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}